Credit Suisse Ag Dexcom Inc Put Options Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $168,831 - $211,666	1,300 Added 11.61%	12,500 $6.71 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $1.14 Million - $1.52 Million	-14,100 Reduced 55.73%	11,200 $4.78 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $101,748 - $125,688	1,200 Added 4.98%	25,300 $9.09 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $1.66 Million - $2.23 Million	21,300 Added 760.71%	24,100 $8.91 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $267,428 - $316,260	2,800 New	2,800 $1.15 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.